|
Market Closed -
Nasdaq
16:00:00 2026-10-08 EDT
|
5-day change | 1st Jan Change | ||
| 2.100 USD | 0.00% |
|
+1.45% | -0.47% |
| 09-16 | Acumen Pharmaceuticals, Inc. - Analyst/Investor Day | |
| 09-10 | Acumen Pharmaceuticals, Inc. Presents at Citigroup?s Biopharma Back to School Summit 2026, Sep-10-2026 08:40 AM |
| Market Cap | 152M 136M 127M 115M 216M 14.71B 218M 1.52B 594M 7.47B 570M 558M 24.04B | P/E 2026 * |
-1.42x | P/E 2027 * | -1.39x |
|---|---|---|---|---|---|
| Enterprise Value | -127M -113M -106M -96.13M -181M -12.3B -183M -1.27B -497M -6.25B -477M -467M -20.11B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
93.21% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ABOS | Delayed | |
CBOE
| ABOS | Real-time |
Last Transcript: Acumen Pharmaceuticals, Inc.
| 1 week | +1.45% | ||
| Current month | -5.41% | ||
| 1 month | -33.54% | ||
| 3 months | -23.08% | ||
| 6 months | -18.60% | ||
| Current year | -0.47% |
| 1 week | 2 |  | 2.17 |
| 1 month | 2 | | 3.02 |
| Current year | 1.67 | | 3.6 |
| 1 year | 1.5 | | 3.6 |
| 3 years | 0.86 | | 5.09 |
| 5 years | 0.86 | | 15.34 |
| 10 years | 0.86 | | 26.98 |
| Manager | Title | Age | Since |
|---|---|---|---|
Daniel O'Connell
CEO | Chief Executive Officer | 56 | 2014-11-30 |
Jim Doherty
PSD | President | 58 | 2024-01-31 |
Matthew Zuga
DFI | Director of Finance/CFO | 60 | 2021-04-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Daniel O'Connell
BRD | Director/Board Member | 56 | 2006-03-31 |
Jeffrey Ives
BRD | Director/Board Member | 75 | 2014-04-30 |
Sean Stalfort
CHM | Chairman | 56 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 6/3/26 | Free | Director | 88,750 | 0.1229% | ||
| 6/3/26 | Free | Director | 88,750 | 0.1229% | ||
| 6/3/26 | Free | Director | 88,750 | 0.1229% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | +1.45% | +11.70% | -52.33% | 152M | |
| -3.19% | -3.19% | +44.60% | +87.98% | 74.68B | |
| -15.86% | -16.16% | +2.68% | +50.90% | 58.7B | |
| -2.39% | +0.50% | +3.41% | +31.33% | 48.36B | |
| -6.35% | -8.63% | +293.39% | +651.28% | 43.05B | |
| +0.30% | -0.71% | +29.05% | +30.33% | 42.48B | |
| -3.82% | -2.41% | -0.27% | +101.36% | 41.39B | |
| -2.13% | -2.18% | +7.51% | +50.31% | 31.29B | |
| -3.35% | -4.95% | -13.38% | -17.22% | 23.93B | |
| -1.24% | -7.47% | -37.90% | +311.13% | 22.22B | |
| Average | -3.80% | -4.10% | +34.08% | +124.51% | 38.63B | |
| Weighted average by Cap. | -4.86% | -4.67% | +42.93% | +136.35% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -112M -99.69M -93M -84.48M -159M -10.81B -161M -1.12B -437M -5.49B -419M -410M -17.67B | -134M -120M -112M -102M -191M -13.01B -193M -1.34B -525M -6.61B -504M -493M -21.26B |
| Net Debt | -279M -249M -232M -211M -397M -27.01B -401M -2.79B -1.09B -13.73B -1.05B -1.02B -44.14B | -376M -336M -313M -284M -535M -36.4B -540M -3.76B -1.47B -18.49B -1.41B -1.38B -59.48B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-08 | US$2.100 | 0.00% | 505,169 |
| 26-10-07 | US$2.100 | +3.45% | 623,092 |
| 26-10-06 | US$2.030 | -4.69% | 562,868 |
| 26-10-05 | US$2.130 | +4.41% | 713,980 |
| 26-10-02 | US$2.040 | -1.45% | 580,519 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ABOS Stock
Select your edition
All financial news and data tailored to specific country editions
